NPI registry status
Active
2026 NPPES data Hematology & Oncology Physician NPI 1316222433 M.D.
Verify on CMS → Faisal Akbar, M.D.
Hematology & Oncology Physician in Monroeville, Pennsylvania.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,530 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
942
Medicare Part D claims · 197 beneficiaries · Hematology & Oncology Physician avg: 885
Generic prescribing
74%
generic claims · 26% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$39.55
2 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Faisal Akbar, M.D. filed 942 Medicare Part D claims in 2024 as a Hematology & Oncology Physician in Monroeville, Pennsylvania, prescribing 74% generic.
- 942
- Part D claims, 2024
- 74%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥74th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Faisal Akbar, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1316222433), first enumerated 10/20/2011.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 942 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$39.55 in reported industry payments (2 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Pennsylvania statewide board action statistics are published annually — these figures describe aggregate state activity, not Faisal Akbar, M.D.'s individual license status. Verify directly with the state medical board.
Source: PA-BOM annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1316222433 · Hematology & Oncology Physician
NPI-10 · ENUM-MID · TAX-MID · RX-LIGHT · BOOK-LIGHT · PHOTO-ENUM
- NPI-10 1316222433
- ENUM-MID 2011
- TAX-MID 12K Hematology &
- RX-LIGHT 942
- BOOK-LIGHT 657 in Pennsylvania
- PHOTO-ENUM Aaron Henderson · 2011
Faisal Akbar, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
942 ≥ 74th percentile 74% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Faisal Akbar, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Faisal Akbar, M.D.?
Quality data not reportedPrimary specialty
Hematology & Oncology Physician
Medicare Part D claims
942 6% vs specialty avg
Specialty distribution in Pennsylvania
How Hematology & Oncology Physician compares to other specialties among Pennsylvania providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Hematology & Oncology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1316222433 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 10/20/2011 |
Hospital and facility affiliations
Facilities where Faisal Akbar, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Oncology Hematology Association Inc
Monroeville, PA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Faisal Akbar, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$40
Largest payer
ADC Therapeutics America, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Pennsylvania PA-BOM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 - they are NOT specific to Faisal Akbar, M.D.. To verify Faisal Akbar, M.D.'s current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases
PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Faisal Akbar, M.D. - brand share 26.0%
Hematology & Oncology Physician average
26% brand-name claims vs 74% generic, on 942 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
942
Total Claims
$1.7M
Total Drug Cost
197
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,426.133
- Total Day Supply
- 38,989
- Brand vs Generic
- 26% brand / 74% generic
- Brand Drug Cost
- $1.5M
- Generic Drug Cost
- $166K
- Opioid Claims
- 69 (7.3% rate)
- Antibiotic Claims
- 12
Patient Demographics
- Average Patient Age
- 74.2 years
- Avg HCC Risk Score
- 1.87
- Gender Split
- 65% female / 35% male
- Age Distribution
- <65: 11, 65-74: 92, 75-84: 73, 85+: 21
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Faisal Akbar, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Anastrozole
Anastrozole
151 claims
- Eliquis
Eliquis
127 claims
- Gabapentin 53
Gabapentin
53 claims
- Prednisone 44
Prednisone
44 claims
- Prochlorperazine M… 37
Prochlorperazine Maleate
37 claims
- Letrozole 32
Letrozole
32 claims
- Xarelto 30
Xarelto
30 claims
- Xtandi 30
Xtandi
30 claims
| Drug | Claims |
|---|---|
| Anastrozole | 151 |
| Eliquis Apixaban | 127 |
| Gabapentin | 53 |
| Prednisone | 44 |
| Prochlorperazine Maleate | 37 |
| Letrozole | 32 |
| Xarelto Rivaroxaban | 30 |
| Xtandi Enzalutamide | 30 |
| Oxycodone Hcl | 27 |
| Dexamethasone | 26 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How Faisal Akbar, M.D. fits within the Hematology & Oncology Physician landscape nationally.
11,530
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
885
Avg Claims per Provider
Faisal Akbar, M.D.'s 942 claims are above the specialty average of 885.
Nationwide Hematology & Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Akbar, both outside Pennsylvania so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2011)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Hematology & Oncology Physician Providers in Pennsylvania
Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as Akbar.
One of 657 Hematology & Oncology Physician providers enrolled in Pennsylvania, 5 are shown here.
Dr. Abdullateef Abdulkareem
M.D.
Lancaster, PA
Dr. Charles Abrams
MD
Philadelphia, PA
Tala Achkar
Pittsburgh, PA
Dr. Monica Adedeji
MD, MPH
Hershey, PA
Dr. Giridhar Adiga
MD
Ephrata, PA
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Faisal Akbar, M.D.'s specialty? ▼
Faisal Akbar, M.D. specializes in Hematology & Oncology Physician and practices in Monroeville, Pennsylvania. Credentials: M.D..
How much does Faisal Akbar, M.D. prescribe under Medicare Part D? ▼
In 2024, Faisal Akbar, M.D. wrote 942 Medicare Part D claims totaling $1.7M in drug costs for 197 beneficiaries.
Where is Faisal Akbar, M.D. located? ▼
Faisal Akbar, M.D. is located at 400 OXFORD DR STE 102, Monroeville, PA, 15146. Phone: (412) 380-2821.
What is Faisal Akbar, M.D.'s NPI number? ▼
Faisal Akbar, M.D.'s National Provider Identifier (NPI) is 1316222433, issued on 10/20/2011.
Does Faisal Akbar, M.D. prescribe more brand-name or generic drugs? ▼
Faisal Akbar, M.D.'s prescribing is 26% brand-name and 74% generic drugs by claim count, with $1.5M in brand drug costs.
Does Faisal Akbar, M.D. prescribe opioids? ▼
Yes, Faisal Akbar, M.D. had 69 opioid claims in 2024 with an opioid prescribing rate of 7.3%.
How many Hematology & Oncology Physician providers are there in the US? ▼
There are 11,530 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 885 Medicare Part D claims per year.
What drugs does Faisal Akbar, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Faisal Akbar, M.D.'s most frequently prescribed drugs include Anastrozole, Eliquis, Gabapentin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Faisal Akbar, M.D. accept Medicare? ▼
Faisal Akbar, M.D. appears in CMS Medicare data with 942 Part D claims and 197 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Faisal Akbar, M.D.'s credentials? ▼
Faisal Akbar, M.D.'s NPI is 1316222433 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.